09 February 2021>: Clinical Research
Evaluation of Mitral and Aortic Valvular Disease and Left Ventricular Dysfunction in a Lebanese Population: Retrospective Single-Center Experience
Vanessa Nader 12ABCDEF , Anthony Matta 13ABDEF , Ronan Canitrot 1ADEF , Romain Itier 1DEF , Pascale Salemeh 2ACF , Olivier Lairez 1EF , Meyer Elbaz 1AEF , Michel Galinier 1AEF , Rania Azar 2ADEF , Jerome Roncalli 1ADEF*DOI: 10.12659/MSM.928218
Med Sci Monit 2021; 27:e928218
Table 4 Distribution of valvular heart disease according to types of left ventricular dysfunction.
Diastolic dysfunction | Systolic dysfunction | ||||||
---|---|---|---|---|---|---|---|
No | Yes | P value | No | Yes | P value | ||
No | 1410, 78% | 1670, 62% | 2580, 70% | 500, 62% | |||
Yes | 405, 22% | 1035, 38% | 1130, 30% | 310, 38% | |||
No | 1485, 82% | 1995, 74% | 2900, 78% | 580, 72% | |||
Yes | 330, 18% | 710, 26% | 810, 22% | 230, 18% | |||
No | 1730, 95% | 2390, 88% | 3395, 92% | 725, 90% | 0.69 | ||
Yes | 85, 5% | 315, 12% | 315, 8% | 85, 10% | |||
No | 1090, 60% | 1280, 47% | 2125, 57% | 245, 30% | |||
Yes | 725, 40% | 1425, 53% | 1585, 43% | 565, 70% | |||
No | 1115, 61% | 1305, 48% | 2145, 58% | 275, 34% | |||
Yes | 700, 39% | 1400, 52% | 1565, 42% | 535, 66% | |||
No | 1800, 99% | 2670, 99% | 0.14 | 3685, 99% | 785, 97% | ||
Yes | 15, 1% | 35, 1% | 25, 1% | 25, 3% | |||
No | 1540, 85% | 2010, 74% | 2990, 81% | 560, 69% | |||
Yes | 275, 15% | 695, 26% | 720, 19% | 250, 31% | |||
No | 1115, 61% | 1535, 57% | 0.002 | 2255, 61% | 395, 49% | ||
Yes | 700, 39% | 1170, 43% | 1455, 39% | 415, 51% | |||
AMVD – aorto-mitral valve disease; AVD – aortic valve disease; AVR – aortic valve regurgitation; AVS – aortic valve stenosis; MVD – mitral valve disease; MVR – mitral valve regurgitation; MVS – mitral valve stenosis; TR – tricuspid regurgitation. |